Proshares Trust (ZBIO) Enterprise Value (2023 - 2025)
Historic Enterprise Value for Zenas BioPharma (ZBIO) over the last 3 years, with Q3 2025 value amounting to -$476.9 million.
- Zenas BioPharma's Enterprise Value fell 3243.08% to -$476.9 million in Q3 2025 from the same period last year, while for Sep 2025 it was -$476.9 million, marking a year-over-year decrease of 3243.08%. This contributed to the annual value of -$350.8 million for FY2024, which is 51692.67% down from last year.
- Zenas BioPharma's Enterprise Value amounted to -$476.9 million in Q3 2025, which was down 3243.08% from -$504.2 million recorded in Q2 2025.
- In the past 5 years, Zenas BioPharma's Enterprise Value ranged from a high of -$37.2 million in Q1 2024 and a low of -$504.2 million during Q2 2025
- Over the past 3 years, Zenas BioPharma's median Enterprise Value value was -$350.8 million (recorded in 2024), while the average stood at -$274.7 million.
- The largest annual percentage gain for Zenas BioPharma's Enterprise Value in the last 5 years was 3243.08% (2025), contrasted with its biggest fall of 105473.95% (2025).
- Quarter analysis of 3 years shows Zenas BioPharma's Enterprise Value stood at -$56.9 million in 2023, then tumbled by 516.93% to -$350.8 million in 2024, then crashed by 35.97% to -$476.9 million in 2025.
- Its Enterprise Value was -$476.9 million in Q3 2025, compared to -$504.2 million in Q2 2025 and -$430.0 million in Q1 2025.